Delivery Order SPE2DB20D1100-SPE2DB25FE0KY
- Not listed
- The Defense Logistics Agency awarded a $3,384 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Corporate Office) on January 30, 2026, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit packages, with an ultimate completion date of February 2, 2026. This non-set-aside contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a child contract under Cencora, Inc. (the parent company operating as AmerisourceBergen), which...
- The Defense Logistics Agency awarded a $3,539.65 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit packaging, with completion scheduled for November 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a $24,425.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count supply) on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside contract will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate office. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements through the...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.48 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This non-competitive, firm fixed price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 30-count packages, valued at $3,309.99. The contract, awarded on October 28, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of October 29, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,045.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% eye emulsion (30-count units), with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,522.35 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $3,926.47 and an ultimate completion date of November 19, 2025. This non-set-aside delivery order employs firm fixed price pricing and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The work will be performed at the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0KYDelivery Order
The Defense Logistics Agency awarded a $3,995.88 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 units) with a completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency and broader military healthcare systems. The company has demonstrated capability to fulfill federal requirements through open, competitive procurement across diverse therapeutic domains including specialty medications, vaccines, and medical devices. This particular delivery order for an ophthalmic immunosuppressant represents a routine transaction within the company's ongoing pharmaceutical distribution support to the federal government's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/17/25 |